Majority of naloxone recipients in NYC at high risk of overdose

The overwhelming majority of those in New York City who obtained a naloxone kit to counteract opioid overdose had a high need for the drug, according to a new study by Weill Cornell Medicine investigators and the New York City Department of Health and Mental Hygiene.

J&J makes another I&I acquisition with $1.25B deal for Numab’s Yellow Jersey

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 29, 2024

RTLS In Healthcare: Optimizing ROI for Health Systems

Scott Hondros, MHA, SCPM, VP of Customer Excellence & Strategic Consulting at CenTrak The last few years have caused significant disruption and constraints of budgets,

August 24, 2023

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.